AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36113023 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretrial dietary fiber intake
Number of subjects: 368
Study 34292305 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 261
Study 34292305 — intervention group
Group type: COMPARATOR
Intervention: No Carboplatin (Control)
Number of subjects: 261
Study 34292305 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin in group 3 subgroup
Number of subjects: 261
Study 34292305 — intervention group
Group type: COMPARATOR
Intervention: No Carboplatin in group 3 subgroup (Control)
Number of subjects: 261
Study 34292305 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival by molecular subgroup
Number of subjects: 261
Study 33806904 — intervention group
Group type: EXPERIMENTAL
Intervention: Green synthesized ZnO-NPs (GS1)
Number of subjects: 150
Study 33806904 — intervention group
Group type: COMPARATOR
Intervention: Commercially available ZnO-NPs (C1)
Number of subjects: 150
Study 33806904 — intervention group
Group type: COMPARATOR
Intervention: Commercially available ZnO-NPs (C2)
Number of subjects: 150
Study 33806904 — intervention group
Group type: COMPARATOR
Intervention: Control (0% ZnO-NPs)
Number of subjects: 150
Study 33806904 — intervention group
Group type: EXPERIMENTAL
Intervention: Green synthesized ZnO-NPs (GS2)
Number of subjects: 150
Study 33806904 — intervention group
Group type: EXPERIMENTAL
Intervention: All experimental groups (exposed to ZnO-NPs)
Number of subjects: 150
Study 32433914 — intervention group
Group type: EXPERIMENTAL
Intervention: Fork-tip needles (22-gauge and 25-gauge)
Number of subjects: 192
Study 32433914 — intervention group
Group type: EXPERIMENTAL
Intervention: Fork-tip needles
Number of subjects: 192
Study 32433914 — intervention group
Group type: COMPARATOR
Intervention: Side-fenestrated needles
Number of subjects: 192
Study 34045151 — intervention group
Group type: EXPERIMENTAL
Intervention: AI‐enabled automatic segmentation
Number of subjects: 3
Study 32176175 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic therapy and observation
Number of subjects: 20
Study 34859313 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry suction technique
Number of subjects: 51
Study 34859313 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet suction technique
Number of subjects: 51
Study 34859313 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow pull technique
Number of subjects: 51
Study 34859313 — intervention group
Group type: EXPERIMENTAL
Intervention: 22G FNB needle design 1
Number of subjects: 51
Study 34859313 — intervention group
Group type: EXPERIMENTAL
Intervention: 22G FNB needle design 2
Number of subjects: 51
Study 34859313 — intervention group
Group type: COMPARATOR
Intervention: Overall results
Number of subjects: 51
Study 32998523 — intervention group
Group type: COMPARATOR
Intervention: Conventional transhiatal esophagectomy
Number of subjects: 62
Study 32998523 — intervention group
Group type: EXPERIMENTAL
Intervention: Transhiatal esophagectomy using a mediastinoscope
Number of subjects: 62
Study 33500282 — intervention group
Group type: EXPERIMENTAL
Intervention: Deprexis (online intervention) in addition to care as usual (CAU)
Number of subjects: 1013
Study 33500282 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 1013
Study 33406543 — intervention group
Group type: EXPERIMENTAL
Intervention: NICaS group (n=68)
Number of subjects: 200
Study 33406543 — intervention group
Group type: EXPERIMENTAL
Intervention: Picco group (n=67)
Number of subjects: 200
Study 33406543 — intervention group
Group type: COMPARATOR
Intervention: Experience group (n=65)
Number of subjects: 200
Study 33406543 — intervention group
Group type: EXPERIMENTAL
Intervention: NICaS group
Number of subjects: 200
Study 33406543 — intervention group
Group type: EXPERIMENTAL
Intervention: Picco group
Number of subjects: 200
Study 35410308 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-school social-marketing intervention to promote sexual health
Number of subjects: 6440
Study 32735114 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidirectional walking (WALK)
Number of subjects: 35
Study 32735114 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CONT)
Number of subjects: 35
Study 34936978 — intervention group
Group type: EXPERIMENTAL
Intervention: Choropleth map
Number of subjects: 0
Study 34936978 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated-circle map
Number of subjects: 0
Study 34936978 — intervention group
Group type: EXPERIMENTAL
Intervention: Thematic maps (Choropleth and Graduated-circle)
Number of subjects: 0
Study 34936978 — intervention group
Group type: COMPARATOR
Intervention: Tabular data
Number of subjects: 0
Study 34936978 — intervention group
Group type: EXPERIMENTAL
Intervention: Past occurrence information (2016 ZIKV outbreaks)
Number of subjects: 0
Study 33320856 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplex RT-qPCR assay for SARS-CoV-2 detection
Number of subjects: 0
Study 33320856 — intervention group
Group type: COMPARATOR
Intervention: Commercial assays
Number of subjects: 0
Study 32790904 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine (15 mg/daily)
Number of subjects: 150
Study 32790904 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine (20 mg/daily)
Number of subjects: 150
Study 32790904 — intervention group
Group type: COMPARATOR
Intervention: Sertraline (50 mg/daily)
Number of subjects: 150
Study 32790904 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram (10 mg/daily)
Number of subjects: 150
Study 32790904 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine (60 mg/daily)
Number of subjects: 150
Study 35087644 — intervention group
Group type: EXPERIMENTAL
Intervention: Vignettes describing killing an innocent civilian
Number of subjects: 0
Study 35087644 — intervention group
Group type: COMPARATOR
Intervention: Vignettes describing killing a person carrying a bomb
Number of subjects: 0
Study 35087644 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptions of police officers enforcing COVID-19 restrictions
Number of subjects: 0
Study 32228545 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-health goal (looking better)
Number of subjects: 407
Study 32228545 — intervention group
Group type: COMPARATOR
Intervention: Health goal (increasing life expectancy)
Number of subjects: 407
Study 34881520 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP‐SD
Number of subjects: 66
Study 34881520 — intervention group
Group type: COMPARATOR
Intervention: Dummy intervention
Number of subjects: 66
Study 34006069 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration with titanium‐reinforced polytetrafluoroethylene membrane and simultaneous implant placement (Group A)
Number of subjects: 40
Study 34006069 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided bone regeneration with titanium mesh and collagen membrane and simultaneous implant placement (Group B)
Number of subjects: 40
Study 32027683 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization test in multiple baseline design
Number of subjects: 0
Study 34534293 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vitamin D sufficiency (25(OH)D ≥ 30 ng/ml) in the third trimester
Number of subjects: 680
Study 34534293 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal 25(OH)D sufficiency category
Number of subjects: 680
Study 34534293 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vitamin D sufficiency among males
Number of subjects: 680
Study 34958861 — intervention group
Group type: EXPERIMENTAL
Intervention: 6'-Sialyllactose (6'-SL), 3 g powder orally administered twice a day for 12 weeks
Number of subjects: 0
Study 34958861 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin), 3 g powder orally administered twice a day for 12 weeks
Number of subjects: 0
Study 33755835 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum CYR61 ≥ 236.2 pg/mL
Number of subjects: 72
Study 33755835 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum CYR61
Number of subjects: 72
Study 34593076 — intervention group
Group type: COMPARATOR
Intervention: Control CCC
Number of subjects: 24
Study 33227631 — intervention group
Group type: EXPERIMENTAL
Intervention: NMOSD patients (with history of optic neuritis)
Number of subjects: 98
Study 33227631 — intervention group
Group type: EXPERIMENTAL
Intervention: NMOSD patients (without history of optic neuritis)
Number of subjects: 98
Study 33227631 — intervention group
Group type: EXPERIMENTAL
Intervention: RRMS patients (with and without history of optic neuritis)
Number of subjects: 98
Study 33227631 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HCs)
Number of subjects: 98
Study 33380333 — intervention group
Group type: EXPERIMENTAL
Intervention: Daubechies-3 wavelet with 7 levels of WT
Number of subjects: 105
Study 33380333 — intervention group
Group type: EXPERIMENTAL
Intervention: Symlets-3 wavelet with 7 levels of WT
Number of subjects: 105
Study 33380333 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavelet transforms in general
Number of subjects: 105
Study 33380333 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusoidal waves
Number of subjects: 105
Study 33380333 — intervention group
Group type: EXPERIMENTAL
Intervention: Step functions
Number of subjects: 105
Study 33380333 — intervention group
Group type: EXPERIMENTAL
Intervention: Spike functions
Number of subjects: 105
Study 35348021 — intervention group
Group type: EXPERIMENTAL
Intervention: diazepam (10 mg)
Number of subjects: 40
Study 35348021 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 34597375 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation radiotherapy (RT)
Number of subjects: 116
Study 34597375 — intervention group
Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 116
Study 32627641 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted MAP at age ≤55 years
Number of subjects: 0
Study 32627641 — intervention group
Group type: COMPARATOR
Intervention: Genetically predicted MAP at age >55 years
Number of subjects: 0
Study 33713473 — intervention group
Group type: EXPERIMENTAL
Intervention: Trapezius muscle injection (TMI) with 5 mL of 0.25% bupivacaine two times, with a 1-week interval
Number of subjects: 60
Study 33713473 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 20 mL of 0.125% bupivacaine in the second week after TMI
Number of subjects: 60
Study 33713473 — intervention group
Group type: COMPARATOR
Intervention: Repeated TMI (two injections)
Number of subjects: 60
Study 33451343 — intervention group
Group type: EXPERIMENTAL
Intervention: Miniscrew anchorage
Number of subjects: 22
Study 33451343 — intervention group
Group type: COMPARATOR
Intervention: Trans palatal arch (TPA) anchorage
Number of subjects: 22
Study 35428952 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bout of eccentric exercise 1 week prior to tissue sampling
Number of subjects: 30
Study 35428952 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bout of eccentric exercise
Number of subjects: 30
Study 35428952 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 30
Study 32205201 — intervention group
Group type: COMPARATOR
Intervention: Control (PA0) - adhesive ExciTE F applied as per the manufacturer's recommendations
Number of subjects: 45
Study 32205201 — intervention group
Group type: EXPERIMENTAL
Intervention: PA2 - 2 wt% proanthocyanidins solution applied for 60s
Number of subjects: 45
Study 32205201 — intervention group
Group type: EXPERIMENTAL
Intervention: PA5 - 5 wt% proanthocyanidins solution applied for 60s
Number of subjects: 45
Study 32205201 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (PA0, PA2, PA5)
Number of subjects: 45
Study 34648685 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg PO daily)
Number of subjects: 65
Study 34648685 — intervention group
Group type: COMPARATOR
Intervention: Finasteride (2.5 mg PO daily) in combination with topical clindamycin 2% solution
Number of subjects: 65
Study 32278330 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional open-ended needle
Number of subjects: 100
Study 32278330 — intervention group
Group type: COMPARATOR
Intervention: Double side-vented needle
Number of subjects: 100
Study 33016187 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual care (VC) including digital symptoms collection and telemedicine in addition to usual in-person physician consultation
Number of subjects: 28
Study 33016187 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual care (VC)
Number of subjects: 28
Study 34010679 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited Restrictions group (normal activities other than pelvic rest)
Number of subjects: 36
Study 34010679 — intervention group
Group type: COMPARATOR
Intervention: Restrictions group (traditional postoperative restrictions for 6 weeks)
Number of subjects: 36
Study 34010679 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited Restrictions group
Number of subjects: 36
Study 34010679 — intervention group
Group type: COMPARATOR
Intervention: Restrictions group
Number of subjects: 36
Study 32788673 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsive feeding promotion from birth to 24 months
Number of subjects: 0
Study 32788673 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36013498 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical instillation of 0.3% ofloxacin, 4 drops at 15 min intervals before surgery
Number of subjects: 91
Study 32125197 — intervention group
Group type: EXPERIMENTAL
Intervention: Bibloc appliance
Number of subjects: 302
Study 32125197 — intervention group
Group type: COMPARATOR
Intervention: Monobloc appliance
Number of subjects: 302
Study 35178811 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg once a day)
Number of subjects: 48
Study 35178811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 32183336 — intervention group
Group type: EXPERIMENTAL
Intervention: Libraries 2% and 3% variants
Number of subjects: 3000
Study 32183336 — intervention group
Group type: EXPERIMENTAL
Intervention: Libraries 5 and 6 variants
Number of subjects: 3000
Study 32183336 — intervention group
Group type: EXPERIMENTAL
Intervention: Variant P5F3 (F41L‐ΔW42‐ΔD43‐K44P) from library 3
Number of subjects: 3000
Study 32183336 — intervention group
Group type: EXPERIMENTAL
Intervention: Variant P5F3
Number of subjects: 3000
Study 32183336 — intervention group
Group type: COMPARATOR
Intervention: Wildtype BSLA
Number of subjects: 3000
Study 35501628 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandated case review for high-risk opioid patients
Number of subjects: 44042
Study 35501628 — intervention group
Group type: COMPARATOR
Intervention: Non-mandated case review for high-risk opioid patients
Number of subjects: 44042
Study 32375754 — intervention group
Group type: EXPERIMENTAL
Intervention: iCBT (internet-based cognitive-behavioral therapy) intervention for PTSD, 5 weeks duration, 10 writing assignments (twice a week)
Number of subjects: 37
Study 32375754 — intervention group
Group type: EXPERIMENTAL
Intervention: iCBT (internet-based cognitive-behavioral therapy) intervention for PTSD
Number of subjects: 37
Study 32375754 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 37
Study 36422503 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (Group A)
Number of subjects: 80
Study 36422503 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (Group B)
Number of subjects: 80
Study 35061635 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop vasopressor (CLV) system
Number of subjects: 40
Study 35061635 — intervention group
Group type: COMPARATOR
Intervention: Control group (manual adjustment by ICU nurse)
Number of subjects: 40
Study 33677626 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked meals (gelatinised starch)
Number of subjects: 18
Study 33677626 — intervention group
Group type: EXPERIMENTAL
Intervention: Finely milled whole-wheat
Number of subjects: 18
Study 33677626 — intervention group
Group type: COMPARATOR
Intervention: Uncooked meals (native starch)
Number of subjects: 18
Study 32202366 — intervention group
Group type: EXPERIMENTAL
Intervention: RMT
Number of subjects: 176
Study 32202366 — intervention group
Group type: EXPERIMENTAL
Intervention: SWAT-T
Number of subjects: 176
Study 32202366 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective applications
Number of subjects: 176
Study 32202366 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially effective applications
Number of subjects: 176
Study 35018508 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg three times a day
Number of subjects: 163
Study 35018508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 33972368 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted CRP concentration
Number of subjects: 16918
Study 33972368 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analyses by stage at diagnosis or tumor location
Number of subjects: 16918
Study 32847391 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined FVIII
Number of subjects: 0
Study 32847391 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined VWF
Number of subjects: 0
Study 32847391 — intervention group
Group type: COMPARATOR
Intervention: FVII, FXI, fibrinogen
Number of subjects: 0
Study 34914339 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy
Number of subjects: 5018
Study 34914339 — intervention group
Group type: COMPARATOR
Intervention: Endocrine-only therapy
Number of subjects: 5018
Study 35241133 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific strengthening of the first dorsal interosseous muscle
Number of subjects: 56
Study 35241133 — intervention group
Group type: COMPARATOR
Intervention: Traditional protocol (control)
Number of subjects: 56
Study 35126921 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative rehabilitation training
Number of subjects: 120
Study 35126921 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical nursing
Number of subjects: 120
Study 34555043 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-free anesthesia with dexmedetomidine, sevoflurane, and thoracic paravertebral blockade
Number of subjects: 97
Study 34555043 — intervention group
Group type: COMPARATOR
Intervention: Opioid-based anesthesia with remifentanil, sevoflurane, and thoracic paravertebral blockade
Number of subjects: 97
Study 35753340 — intervention group
Group type: COMPARATOR
Intervention: No intervention group
Number of subjects: 2397
Study 35753340 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin intervention group
Number of subjects: 2397
Study 35753340 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intervention group
Number of subjects: 2397
Study 35753340 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention group
Number of subjects: 2397
Study 34526318 — intervention group
Group type: EXPERIMENTAL
Intervention: Early percutaneous mitral commissurotomy (PMC)
Number of subjects: 167
Study 34526318 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 167
Study 35191972 — intervention group
Group type: EXPERIMENTAL
Intervention: AI audiovisual metric-based feedback (VOA group)
Number of subjects: 70
Study 35191972 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous verbal scripted debriefing and instruction from a remote expert (instructor group)
Number of subjects: 70
Study 35191972 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 70
Study 33828043 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye examination for low vision rehabilitation
Number of subjects: 201
Study 34139405 — intervention group
Group type: EXPERIMENTAL
Intervention: Music MIP
Number of subjects: 401
Study 34139405 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory MIP
Number of subjects: 401
Study 34139405 — intervention group
Group type: EXPERIMENTAL
Intervention: Music+Memory MIP
Number of subjects: 401
Study 34139405 — intervention group
Group type: COMPARATOR
Intervention: Neutral MIPs
Number of subjects: 401
Study 34098002 — intervention group
Group type: EXPERIMENTAL
Intervention: Best-Worst Scaling for food quality attributes
Number of subjects: 264
Study 34098002 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 264
Study 34327833 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical monotherapy
Number of subjects: 242
Study 34327833 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive approach using drugs from three different classes plus 360° laser trabeculoplasty
Number of subjects: 242
Study 34327833 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 242
Study 34021404 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF + CTG
Number of subjects: 42
Study 34021404 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF + XDM
Number of subjects: 42
Study 34021404 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 32415720 — intervention group
Group type: EXPERIMENTAL
Intervention: CNTO 7160 (3 mg/kg) in patients with AD
Number of subjects: 68
Study 32415720 — intervention group
Group type: EXPERIMENTAL
Intervention: CNTO 7160 (3 or 10 mg/kg) in patients with asthma or AD
Number of subjects: 68
Study 32415720 — intervention group
Group type: EXPERIMENTAL
Intervention: CNTO 7160 (1-10 mg/kg)
Number of subjects: 68
Study 32415720 — intervention group
Group type: EXPERIMENTAL
Intervention: CNTO 7160 (1 mg/kg IV every 2 weeks)
Number of subjects: 68
Study 32415720 — intervention group
Group type: EXPERIMENTAL
Intervention: CNTO 7160
Number of subjects: 68
Study 36071623 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=27) received four one-hour low back pain-related education sessions in addition to eight 45-minute standard physical therapy sessions over 4 weeks.
Number of subjects: 54
Study 33694311 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (ACEi)
Number of subjects: 66
Study 33829819 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Focus on Change (PFC, N = 40)
Number of subjects: 80
Study 33829819 — intervention group
Group type: COMPARATOR
Intervention: State‐Of‐The‐Art (SOTA, N = 40)
Number of subjects: 80
Study 35232389 — intervention group
Group type: EXPERIMENTAL
Intervention: iSupport-Portugal
Number of subjects: 42
Study 35232389 — intervention group
Group type: COMPARATOR
Intervention: Education-only e-book (Control)
Number of subjects: 42
Study 33235115 — intervention group
Group type: EXPERIMENTAL
Intervention: Catgut implantation at acupoints (CIA)
Number of subjects: 216